North American neurological disorder drug is projected to grow at a significant CAGR during the forecast period. The key factors that drive the growth of the market include the rising prevalence of neurological disorders among people across the globe. The rising geriatric population is another major reason for market growth in the North American region. […]
Tag Archives: North American Neurological Disorder Drugs Market
The North American neurological disorder drug industry is growing significantly over the forecast period (2020-2026) owing to the rising prevalence of neurological disorders, rising geriatric population, rapid R&D activities by the players in the region. For instance, in May 2019, Allergan Plc announced to share approximately 29 presentations at the 71st Annual American Academy of […]